APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decentralized Clinical Trial Platforms

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Decentralized Clinical Trial Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 March 2026196 pages

Choose your research edition.

Industry ResearchDecentralized Clinical Trial Platforms Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Decentralized Clinical Trial Platforms Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Decentralized Clinical Trial Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decentralized Clinical Trial Platforms Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Decentralized Clinical Trial Platforms Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Decentralized Clinical Trial Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Decentralized Clinical Trial Platforms include Medidata, IQVIA, Veeva Systems, Castor, Delve Health, Jeeva, Signant Health, Clinical Ink and ObvioHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Decentralized Clinical Trial Platforms market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decentralized Clinical Trial Platforms and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decentralized Clinical Trial Platforms revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Decentralized Clinical Trial Platforms market size, projected growth trends, production technologies, key applications, and end-use industries.

Decentralized Clinical Trial Platforms Segment by Company

Medidata

IQVIA

Veeva Systems

Castor

Delve Health

Jeeva

Signant Health

Clinical Ink

ObvioHealth

THREAD

Science 37

Medable, Clario

Aparito

Viedoc Technologies

Crucial Data Solutions

Medrio

Alira Health

Fortrea

Huma

Cliniv Health Tech

Datacubed Health

Decentralized Clinical Trial Platforms Segment by Type

Cloud Based

Web Based

Decentralized Clinical Trial Platforms Segment by Application

Pharmaceutical Companies

Biotechnology Firms

Contract Research Organizations (CROs)

Healthcare Institutions

Decentralized Clinical Trial Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trial Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trial Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trial Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Decentralized Clinical Trial Platforms in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Decentralized Clinical Trial Platforms industry.

Chapter 3: Detailed analysis of Decentralized Clinical Trial Platforms companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Decentralized Clinical Trial Platformsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cloud Based Table 3. Key Players of Web Based Table 4. Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Companies Table 6. Key Players of Biotechnology Firms Table 7. Key Players of Contract Research Organizations (CROs) Table 8. Key Players of Healthcare Institutions Table 9. Global Decentralized Clinical Trial Platforms Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Decentralized Clinical Trial Platforms Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Decentralized Clinical Trial Platforms Market Share by Region (2021-2026) Table 12. Global Decentralized Clinical Trial Platforms Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Decentralized Clinical Trial Platforms Market Share by Region (2027-2032) Table 14. Decentralized Clinical Trial Platforms Industry Trends Table 15. Decentralized Clinical Trial Platforms Industry Drivers Table 16. Decentralized Clinical Trial Platforms Industry Opportunities and Challenges Table 17. Decentralized Clinical Trial Platforms Industry Restraints Table 18. Global Decentralized Clinical Trial Platforms Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Decentralized Clinical Trial Platforms Revenue Market Share by Company (2021-2026) Table 20. Global Decentralized Clinical Trial Platforms Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Decentralized Clinical Trial Platforms Key Company Head Office and Area Served Table 22. Global Decentralized Clinical Trial Platforms Company, Product Type & Application Table 23. Global Decentralized Clinical Trial Platforms Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Decentralized Clinical Trial Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Decentralized Clinical Trial Platforms Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Decentralized Clinical Trial Platforms Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Decentralized Clinical Trial Platforms Revenue Market Share by Type (2021-2026) Table 30. Global Decentralized Clinical Trial Platforms Revenue Market Share by Type (2027-2032) Table 31. Global Decentralized Clinical Trial Platforms Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Decentralized Clinical Trial Platforms Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Decentralized Clinical Trial Platforms Revenue Market Share by Application (2021-2026) Table 35. Global Decentralized Clinical Trial Platforms Revenue Market Share by Application (2027-2032) Table 36. Medidata Company Information Table 37. Medidata Business Overview Table 38. Medidata Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Medidata Decentralized Clinical Trial Platforms Product Portfolio Table 40. Medidata Recent Development Table 41. IQVIA Company Information Table 42. IQVIA Business Overview Table 43. IQVIA Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. IQVIA Decentralized Clinical Trial Platforms Product Portfolio Table 45. IQVIA Recent Development Table 46. Veeva Systems Company Information Table 47. Veeva Systems Business Overview Table 48. Veeva Systems Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Veeva Systems Decentralized Clinical Trial Platforms Product Portfolio Table 50. Veeva Systems Recent Development Table 51. Castor Company Information Table 52. Castor Business Overview Table 53. Castor Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Castor Decentralized Clinical Trial Platforms Product Portfolio Table 55. Castor Recent Development Table 56. Delve Health Company Information Table 57. Delve Health Business Overview Table 58. Delve Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Delve Health Decentralized Clinical Trial Platforms Product Portfolio Table 60. Delve Health Recent Development Table 61. Jeeva Company Information Table 62. Jeeva Business Overview Table 63. Jeeva Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Jeeva Decentralized Clinical Trial Platforms Product Portfolio Table 65. Jeeva Recent Development Table 66. Signant Health Company Information Table 67. Signant Health Business Overview Table 68. Signant Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Signant Health Decentralized Clinical Trial Platforms Product Portfolio Table 70. Signant Health Recent Development Table 71. Clinical Ink Company Information Table 72. Clinical Ink Business Overview Table 73. Clinical Ink Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Clinical Ink Decentralized Clinical Trial Platforms Product Portfolio Table 75. Clinical Ink Recent Development Table 76. ObvioHealth Company Information Table 77. ObvioHealth Business Overview Table 78. ObvioHealth Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. ObvioHealth Decentralized Clinical Trial Platforms Product Portfolio Table 80. ObvioHealth Recent Development Table 81. THREAD Company Information Table 82. THREAD Business Overview Table 83. THREAD Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. THREAD Decentralized Clinical Trial Platforms Product Portfolio Table 85. THREAD Recent Development Table 86. Science 37 Company Information Table 87. Science 37 Business Overview Table 88. Science 37 Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Science 37 Decentralized Clinical Trial Platforms Product Portfolio Table 90. Science 37 Recent Development Table 91. Medable, Clario Company Information Table 92. Medable, Clario Business Overview Table 93. Medable, Clario Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Medable, Clario Decentralized Clinical Trial Platforms Product Portfolio Table 95. Medable, Clario Recent Development Table 96. Aparito Company Information Table 97. Aparito Business Overview Table 98. Aparito Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Aparito Decentralized Clinical Trial Platforms Product Portfolio Table 100. Aparito Recent Development Table 101. Viedoc Technologies Company Information Table 102. Viedoc Technologies Business Overview Table 103. Viedoc Technologies Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Viedoc Technologies Decentralized Clinical Trial Platforms Product Portfolio Table 105. Viedoc Technologies Recent Development Table 106. Crucial Data Solutions Company Information Table 107. Crucial Data Solutions Business Overview Table 108. Crucial Data Solutions Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Crucial Data Solutions Decentralized Clinical Trial Platforms Product Portfolio Table 110. Crucial Data Solutions Recent Development Table 111. Medrio Company Information Table 112. Medrio Business Overview Table 113. Medrio Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Medrio Decentralized Clinical Trial Platforms Product Portfolio Table 115. Medrio Recent Development Table 116. Alira Health Company Information Table 117. Alira Health Business Overview Table 118. Alira Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Alira Health Decentralized Clinical Trial Platforms Product Portfolio Table 120. Alira Health Recent Development Table 121. Fortrea Company Information Table 122. Fortrea Business Overview Table 123. Fortrea Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Fortrea Decentralized Clinical Trial Platforms Product Portfolio Table 125. Fortrea Recent Development Table 126. Huma Company Information Table 127. Huma Business Overview Table 128. Huma Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Huma Decentralized Clinical Trial Platforms Product Portfolio Table 130. Huma Recent Development Table 131. Cliniv Health Tech Company Information Table 132. Cliniv Health Tech Business Overview Table 133. Cliniv Health Tech Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Cliniv Health Tech Decentralized Clinical Trial Platforms Product Portfolio Table 135. Cliniv Health Tech Recent Development Table 136. Datacubed Health Company Information Table 137. Datacubed Health Business Overview Table 138. Datacubed Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Datacubed Health Decentralized Clinical Trial Platforms Product Portfolio Table 140. Datacubed Health Recent Development Table 141. North America Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 142. North America Decentralized Clinical Trial Platforms Market Size by Type (2027-2032) & (US$ Million) Table 143. North America Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 144. North America Decentralized Clinical Trial Platforms Market Size by Application (2027-2032) & (US$ Million) Table 145. North America Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) Table 147. North America Decentralized Clinical Trial Platforms Market Size by Country (2027-2032) Table 148. Europe Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 149. Europe Decentralized Clinical Trial Platforms Market Size by Type (2027-2032) & (US$ Million) Table 150. Europe Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 151. Europe Decentralized Clinical Trial Platforms Market Size by Application (2027-2032) & (US$ Million) Table 152. Europe Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) Table 154. Europe Decentralized Clinical Trial Platforms Market Size by Country (2027-2032) Table 155. China Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 156. China Decentralized Clinical Trial Platforms Market Size by Type (2027-2032) & (US$ Million) Table 157. China Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 158. China Decentralized Clinical Trial Platforms Market Size by Application (2027-2032) & (US$ Million) Table 159. Asia Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 160. Asia Decentralized Clinical Trial Platforms Market Size by Type (2027-2032) & (US$ Million) Table 161. Asia Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 162. Asia Decentralized Clinical Trial Platforms Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) Table 165. Asia Decentralized Clinical Trial Platforms Market Size by Country (2027-2032) Table 166. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Type (2021-2026) & (US$ Million) Table 167. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Type (2027-2032) & (US$ Million) Table 168. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Application (2021-2026) & (US$ Million) Table 169. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Application (2027-2032) & (US$ Million) Table 170. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2021-2026) Table 172. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Decentralized Clinical Trial Platforms Product Image Figure 2. Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Decentralized Clinical Trial Platforms Market Share by Type: 2025 VS 2032 Figure 4. Cloud Based Image Figure 5. Web Based Image Figure 6. Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Decentralized Clinical Trial Platforms Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceutical Companies Image Figure 9. Biotechnology Firms Image Figure 10. Contract Research Organizations (CROs) Image Figure 11. Healthcare Institutions Image Figure 12. Global Decentralized Clinical Trial Platforms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 14. Global Decentralized Clinical Trial Platforms Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Decentralized Clinical Trial Platforms Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Decentralized Clinical Trial Platforms Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Decentralized Clinical Trial Platforms Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Decentralized Clinical Trial Platforms Revenue Market Share by Type (2021-2032) Figure 21. Global Decentralized Clinical Trial Platforms Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Decentralized Clinical Trial Platforms Revenue Market Share by Application (2021-2032) Figure 23. North America Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 24. North America Decentralized Clinical Trial Platforms Market Share by Type (2021-2032) Figure 25. North America Decentralized Clinical Trial Platforms Market Share by Application (2021-2032) Figure 26. North America Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 27. United States Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 28. Canada Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 30. Europe Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 31. Europe Decentralized Clinical Trial Platforms Market Share by Type (2021-2032) Figure 32. Europe Decentralized Clinical Trial Platforms Market Share by Application (2021-2032) Figure 33. Europe Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 34. Germany Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 35. France Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 37. Italy Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 38. Russia Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 40. China Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 41. China Decentralized Clinical Trial Platforms Market Share by Type (2021-2032) Figure 42. China Decentralized Clinical Trial Platforms Market Share by Application (2021-2032) Figure 43. Asia Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 44. Asia Decentralized Clinical Trial Platforms Market Share by Type (2021-2032) Figure 45. Asia Decentralized Clinical Trial Platforms Market Share by Application (2021-2032) Figure 46. Asia Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 47. Japan Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 51. India Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 52. Australia Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Country (2021-2032) Figure 57. Brazil Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 62. UAE Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 64. Chile Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • Web Based
Applications
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Contract Research Organizations (CROs)
  • Healthcare Institutions
Companies covered
  • Medidata
  • IQVIA
  • Veeva Systems
  • Castor
  • Delve Health
  • Jeeva
  • Signant Health
  • Clinical Ink
  • ObvioHealth
  • THREAD
  • Science 37
  • Medable, Clario
  • Aparito
  • Viedoc Technologies
  • Crucial Data Solutions
  • Medrio
  • Alira Health
  • Fortrea
  • Huma
  • Cliniv Health Tech
  • Datacubed Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud Based
  5. 1.2.3 Web Based
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Decentralized Clinical Trial Platforms Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Companies
  9. 1.3.3 Biotechnology Firms
  10. 1.3.4 Contract Research Organizations (CROs)
  11. 1.3.5 Healthcare Institutions
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Decentralized Clinical Trial Platforms Growth Trends by Region
  14. 1.5.1 Global Decentralized Clinical Trial Platforms Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Decentralized Clinical Trial Platforms Market Size by Region (2021-2026)
  16. 1.5.3 Decentralized Clinical Trial Platforms Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Decentralized Clinical Trial Platforms Market Dynamics
  1. 2.1 Decentralized Clinical Trial Platforms Industry Trends
  2. 2.2 Decentralized Clinical Trial Platforms Industry Drivers
  3. 2.3 Decentralized Clinical Trial Platforms Industry Opportunities and Challenges
  4. 2.4 Decentralized Clinical Trial Platforms Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Decentralized Clinical Trial Platforms Revenue by Company (2021-2026)
  2. 3.2 Global Decentralized Clinical Trial Platforms Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Decentralized Clinical Trial Platforms Key Company Head office and Area Served
  4. 3.4 Global Decentralized Clinical Trial Platforms Company, Product Type & Application
  5. 3.5 Global Decentralized Clinical Trial Platforms Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Decentralized Clinical Trial Platforms Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Decentralized Clinical Trial Platforms Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Decentralized Clinical Trial Platforms Tier 1, Tier 2, and Tier 3
4 Decentralized Clinical Trial Platforms Market by Type
  1. 4.1 Global Decentralized Clinical Trial Platforms Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Decentralized Clinical Trial Platforms Market Size by Type (2021-2032)
  3. 4.3 Global Decentralized Clinical Trial Platforms Market Size Share by Type (2021-2032)
5 Decentralized Clinical Trial Platforms Market by Application
  1. 5.1 Global Decentralized Clinical Trial Platforms Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Decentralized Clinical Trial Platforms Market Size by Application (2021-2032)
  3. 5.3 Global Decentralized Clinical Trial Platforms Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Medidata
  2. 6.1.1 Medidata Company Information
  3. 6.1.2 Medidata Business Overview
  4. 6.1.3 Medidata Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Medidata Decentralized Clinical Trial Platforms Product Portfolio
  6. 6.1.5 Medidata Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 IQVIA Decentralized Clinical Trial Platforms Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 Veeva Systems
  14. 6.3.1 Veeva Systems Company Information
  15. 6.3.2 Veeva Systems Business Overview
  16. 6.3.3 Veeva Systems Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Veeva Systems Decentralized Clinical Trial Platforms Product Portfolio
  18. 6.3.5 Veeva Systems Recent Developments
  19. 6.4 Castor
  20. 6.4.1 Castor Company Information
  21. 6.4.2 Castor Business Overview
  22. 6.4.3 Castor Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Castor Decentralized Clinical Trial Platforms Product Portfolio
  24. 6.4.5 Castor Recent Developments
  25. 6.5 Delve Health
  26. 6.5.1 Delve Health Company Information
  27. 6.5.2 Delve Health Business Overview
  28. 6.5.3 Delve Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Delve Health Decentralized Clinical Trial Platforms Product Portfolio
  30. 6.5.5 Delve Health Recent Developments
  31. 6.6 Jeeva
  32. 6.6.1 Jeeva Company Information
  33. 6.6.2 Jeeva Business Overview
  34. 6.6.3 Jeeva Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Jeeva Decentralized Clinical Trial Platforms Product Portfolio
  36. 6.6.5 Jeeva Recent Developments
  37. 6.7 Signant Health
  38. 6.7.1 Signant Health Company Information
  39. 6.7.2 Signant Health Business Overview
  40. 6.7.3 Signant Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Signant Health Decentralized Clinical Trial Platforms Product Portfolio
  42. 6.7.5 Signant Health Recent Developments
  43. 6.8 Clinical Ink
  44. 6.8.1 Clinical Ink Company Information
  45. 6.8.2 Clinical Ink Business Overview
  46. 6.8.3 Clinical Ink Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Clinical Ink Decentralized Clinical Trial Platforms Product Portfolio
  48. 6.8.5 Clinical Ink Recent Developments
  49. 6.9 ObvioHealth
  50. 6.9.1 ObvioHealth Company Information
  51. 6.9.2 ObvioHealth Business Overview
  52. 6.9.3 ObvioHealth Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ObvioHealth Decentralized Clinical Trial Platforms Product Portfolio
  54. 6.9.5 ObvioHealth Recent Developments
  55. 6.10 THREAD
  56. 6.10.1 THREAD Company Information
  57. 6.10.2 THREAD Business Overview
  58. 6.10.3 THREAD Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 THREAD Decentralized Clinical Trial Platforms Product Portfolio
  60. 6.10.5 THREAD Recent Developments
  61. 6.11 Science 37
  62. 6.11.1 Science 37 Company Information
  63. 6.11.2 Science 37 Business Overview
  64. 6.11.3 Science 37 Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Science 37 Decentralized Clinical Trial Platforms Product Portfolio
  66. 6.11.5 Science 37 Recent Developments
  67. 6.12 Medable, Clario
  68. 6.12.1 Medable, Clario Company Information
  69. 6.12.2 Medable, Clario Business Overview
  70. 6.12.3 Medable, Clario Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Medable, Clario Decentralized Clinical Trial Platforms Product Portfolio
  72. 6.12.5 Medable, Clario Recent Developments
  73. 6.13 Aparito
  74. 6.13.1 Aparito Company Information
  75. 6.13.2 Aparito Business Overview
  76. 6.13.3 Aparito Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Aparito Decentralized Clinical Trial Platforms Product Portfolio
  78. 6.13.5 Aparito Recent Developments
  79. 6.14 Viedoc Technologies
  80. 6.14.1 Viedoc Technologies Company Information
  81. 6.14.2 Viedoc Technologies Business Overview
  82. 6.14.3 Viedoc Technologies Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Viedoc Technologies Decentralized Clinical Trial Platforms Product Portfolio
  84. 6.14.5 Viedoc Technologies Recent Developments
  85. 6.15 Crucial Data Solutions
  86. 6.15.1 Crucial Data Solutions Company Information
  87. 6.15.2 Crucial Data Solutions Business Overview
  88. 6.15.3 Crucial Data Solutions Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Crucial Data Solutions Decentralized Clinical Trial Platforms Product Portfolio
  90. 6.15.5 Crucial Data Solutions Recent Developments
  91. 6.16 Medrio
  92. 6.16.1 Medrio Company Information
  93. 6.16.2 Medrio Business Overview
  94. 6.16.3 Medrio Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Medrio Decentralized Clinical Trial Platforms Product Portfolio
  96. 6.16.5 Medrio Recent Developments
  97. 6.17 Alira Health
  98. 6.17.1 Alira Health Company Information
  99. 6.17.2 Alira Health Business Overview
  100. 6.17.3 Alira Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Alira Health Decentralized Clinical Trial Platforms Product Portfolio
  102. 6.17.5 Alira Health Recent Developments
  103. 6.18 Fortrea
  104. 6.18.1 Fortrea Company Information
  105. 6.18.2 Fortrea Business Overview
  106. 6.18.3 Fortrea Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Fortrea Decentralized Clinical Trial Platforms Product Portfolio
  108. 6.18.5 Fortrea Recent Developments
  109. 6.19 Huma
  110. 6.19.1 Huma Company Information
  111. 6.19.2 Huma Business Overview
  112. 6.19.3 Huma Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Huma Decentralized Clinical Trial Platforms Product Portfolio
  114. 6.19.5 Huma Recent Developments
  115. 6.20 Cliniv Health Tech
  116. 6.20.1 Cliniv Health Tech Company Information
  117. 6.20.2 Cliniv Health Tech Business Overview
  118. 6.20.3 Cliniv Health Tech Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Cliniv Health Tech Decentralized Clinical Trial Platforms Product Portfolio
  120. 6.20.5 Cliniv Health Tech Recent Developments
  121. 6.21 Datacubed Health
  122. 6.21.1 Datacubed Health Company Information
  123. 6.21.2 Datacubed Health Business Overview
  124. 6.21.3 Datacubed Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Datacubed Health Decentralized Clinical Trial Platforms Product Portfolio
  126. 6.21.5 Datacubed Health Recent Developments
7 North America
  1. 7.1 North America Decentralized Clinical Trial Platforms Market Size (2021-2032)
  2. 7.2 North America Decentralized Clinical Trial Platforms Market Size by Type
  3. 7.2.1 North America Decentralized Clinical Trial Platforms Market Size by Type (2021-2026)
  4. 7.2.2 North America Decentralized Clinical Trial Platforms Market Size by Type (2027-2032)
  5. 7.2.3 North America Decentralized Clinical Trial Platforms Market Share by Type (2021-2032)
  6. 7.3 North America Decentralized Clinical Trial Platforms Market Size by Application
  7. 7.3.1 North America Decentralized Clinical Trial Platforms Market Size by Application (2021-2026)
  8. 7.3.2 North America Decentralized Clinical Trial Platforms Market Size by Application (2027-2032)
  9. 7.3.3 North America Decentralized Clinical Trial Platforms Market Share by Application (2021-2032)
  10. 7.4 North America Decentralized Clinical Trial Platforms Market Size by Country
  11. 7.4.1 North America Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  13. 7.4.3 North America Decentralized Clinical Trial Platforms Market Size by Country (2027-2032)
  14. 7.4.4 North America Decentralized Clinical Trial Platforms Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Decentralized Clinical Trial Platforms Market Size (2021-2032)
  2. 8.2 Europe Decentralized Clinical Trial Platforms Market Size by Type
  3. 8.2.1 Europe Decentralized Clinical Trial Platforms Market Size by Type (2021-2026)
  4. 8.2.2 Europe Decentralized Clinical Trial Platforms Market Size by Type (2027-2032)
  5. 8.2.3 Europe Decentralized Clinical Trial Platforms Market Share by Type (2021-2032)
  6. 8.3 Europe Decentralized Clinical Trial Platforms Market Size by Application
  7. 8.3.1 Europe Decentralized Clinical Trial Platforms Market Size by Application (2021-2026)
  8. 8.3.2 Europe Decentralized Clinical Trial Platforms Market Size by Application (2027-2032)
  9. 8.3.3 Europe Decentralized Clinical Trial Platforms Market Share by Application (2021-2032)
  10. 8.4 Europe Decentralized Clinical Trial Platforms Market Size by Country
  11. 8.4.1 Europe Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  13. 8.4.3 Europe Decentralized Clinical Trial Platforms Market Size by Country (2027-2032)
  14. 8.4.4 Europe Decentralized Clinical Trial Platforms Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Decentralized Clinical Trial Platforms Market Size (2021-2032)
  2. 9.2 China Decentralized Clinical Trial Platforms Market Size by Type
  3. 9.2.1 China Decentralized Clinical Trial Platforms Market Size by Type (2021-2026)
  4. 9.2.2 China Decentralized Clinical Trial Platforms Market Size by Type (2027-2032)
  5. 9.2.3 China Decentralized Clinical Trial Platforms Market Share by Type (2021-2032)
  6. 9.3 China Decentralized Clinical Trial Platforms Market Size by Application
  7. 9.3.1 China Decentralized Clinical Trial Platforms Market Size by Application (2021-2026)
  8. 9.3.2 China Decentralized Clinical Trial Platforms Market Size by Application (2027-2032)
  9. 9.3.3 China Decentralized Clinical Trial Platforms Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Decentralized Clinical Trial Platforms Market Size (2021-2032)
  2. 10.2 Asia Decentralized Clinical Trial Platforms Market Size by Type
  3. 10.2.1 Asia Decentralized Clinical Trial Platforms Market Size by Type (2021-2026)
  4. 10.2.2 Asia Decentralized Clinical Trial Platforms Market Size by Type (2027-2032)
  5. 10.2.3 Asia Decentralized Clinical Trial Platforms Market Share by Type (2021-2032)
  6. 10.3 Asia Decentralized Clinical Trial Platforms Market Size by Application
  7. 10.3.1 Asia Decentralized Clinical Trial Platforms Market Size by Application (2021-2026)
  8. 10.3.2 Asia Decentralized Clinical Trial Platforms Market Size by Application (2027-2032)
  9. 10.3.3 Asia Decentralized Clinical Trial Platforms Market Share by Application (2021-2032)
  10. 10.4 Asia Decentralized Clinical Trial Platforms Market Size by Country
  11. 10.4.1 Asia Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  13. 10.4.3 Asia Decentralized Clinical Trial Platforms Market Size by Country (2027-2032)
  14. 10.4.4 Asia Decentralized Clinical Trial Platforms Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Decentralized Clinical Trial Platforms Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst